{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T11:42:48Z","timestamp":1794138168070,"version":"4.8.0"},"reference-count":14,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T00:00:00Z","timestamp":1765670400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Int J Artif Organs"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Achieving adequate sedation on extracorporeal membrane oxygenation (ECMO) is challenging due to altered pharmacokinetics. Limited data exists on phenobarbital in adult ECMO patients. The aim was to characterize the volume of distribution (Vd) and dosing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This single-center retrospective study examined adult ECMO patients who received intravenous phenobarbital and corresponding serum concentrations between January 1, 2017 and March 1, 2024. Phenobarbital levels for analysis were obtained 0.5\u20134\u2009h after phenobarbital loading dose (LD) and up to 4\u2009h prior to a maintenance dose; this time frame was adjusted to 0.5\u20131\u2009h if on continuous venovenous hemofiltration (CVVH).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Sixteen venovenous ECMO patients with 18 LD and 70 phenobarbital concentrations were evaluated. The median LD was 1225\u2009mg (796.3\u20131437.8); 15\u2009mg\/kg (8.8\u201316.2) total body weight (TBW). The median total Vd was 67.7\u2009L (46.8\u201380.8), 0.94\u2009L\/kg (0.72\u20131.22) ideal body weight (IBW), and 0.71\u2009L\/kg (0.67\u20130.82) TBW. Weight-based LD and concentration demonstrated a stronger correlation for TBW (\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      \u2009=\u20090.93,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009&lt;\u20090.001) versus IBW (\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      \u2009=\u20090.64,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.003). Comparing BMI &lt;30 and BMI \u2a7e30\u2009kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      patients there was a difference in total Vd (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.02) and IBW-normalized Vd (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.006), but no difference in TBW-normalized Vd (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.31). The median maintenance dose was 2.4\u2009mg\/kg\/day (1.7\u20132.7) TBW; CVVH patients required 11.7\u2009mg\/kg\/day TBW. Phenobarbital concentration change was &lt;3% after ECMO decannulation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>In adult ECMO patients, phenobarbital\u2019s Vd normalized to TBW, was consistent with critically ill non-ECMO patients. Obesity affected Vd, CVVH influenced maintenance dosing, but ECMO decannulation did not impact phenobarbital concentrations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/03913988251398850","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T06:12:46Z","timestamp":1765779166000},"page":"23-29","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Characterization of phenobarbital pharmacokinetics and dosing in adults receiving extracorporeal membrane oxygenation"],"prefix":"10.1177","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6646-8680","authenticated-orcid":false,"given":"Natasha D","family":"Lopez","sequence":"first","affiliation":[{"name":"Massachusetts General Hospital, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0798-8799","authenticated-orcid":false,"given":"Christina","family":"Jacob","sequence":"additional","affiliation":[{"name":"Boston Medical Center, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tia N","family":"Bullard","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,12,14]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/MAT.0000000000001758"},{"key":"e_1_3_2_3_2","volume-title":"Applied clinical pharmacokinetics","author":"Bauer LA.","year":"2008","unstructured":"Bauer LA. Chapter 13. Phenobarbital\/primidone. In: Bauer LA (ed.) Applied clinical pharmacokinetics (Internet). 2th ed. New York, NY: The McGraw-Hill Companies, 2008.","edition":"2"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0044-1779255"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2023.109104"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm-conference.2024.209.1_MeetingAbstracts.A1564"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2023.08.034"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1743"},{"issue":"1","key":"e_1_3_2_9_2","first-page":"8323","article-title":"Evaluation of intravenous phenobarbital pharmacokinetics in critically ill patients with brain injury","volume":"60","author":"Khezrnia SS","year":"2022","unstructured":"Khezrnia SS, Shahrami B, Rouini MR, et al. Evaluation of intravenous phenobarbital pharmacokinetics in critically ill patients with brain injury. Acta Med Iran 2022; 60(1): 8323.","journal-title":"Acta Med Iran"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1177\/0267659118766444"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-020-03011-x"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115281"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.2165\/11318100-000000000-00000"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199222060-00006"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000046"}],"container-title":["The International Journal of Artificial Organs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03913988251398850","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/03913988251398850","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03913988251398850","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:47:54Z","timestamp":1790052474000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/03913988251398850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,14]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1177\/03913988251398850"],"URL":"https:\/\/doi.org\/10.1177\/03913988251398850","relation":{},"ISSN":["0391-3988","1724-6040"],"issn-type":[{"value":"0391-3988","type":"print"},{"value":"1724-6040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,14]]}}}